Skip to main content

Table 4 Dose levels at end of SR phase

From: A randomized, double-blind comparison of OROS®hydromorphone and controlled-release morphine for the control of chronic cancer pain

 

OROS® hydromorphone (N = 77)

CR morphine (N = 86)

Dose level

Dose (mg) every 24 hours

Number of subjects (%)

Dose (mg) every 12 hours

Number of subjects (%)

1

16

22 (28.6)

30

25 (29.1)

2

24

14 (18.2)

60

23 (26.7)

3

32

18 (23.4)

90

15 (17.4)

4

48

10 (13.0)

120

13 (15.1)

5

72

5 (6.5)

175

8 (9.3)

6

96

8 (10.4)

260

2 (2.3)

  1. Abbreviations: CR, controlled-release; SR, sustained-release
Back to article page

BMC Palliative Care

ISSN: 1472-684X

Contact us